Evidence map›Paper›PMID 39948592›Full record

Trial reportBMC oral health2025

Evaluation of melatonin gel as local drug delivery system for the treatment of periodontitis: a split-mouth randomized controlled trial.

Anjana J Pratap, Rashmi Srinath, N C Praveen, Prerana Sustarwar, Manasa Sadarjoshi, Sultan Abdulrahman Almalki, Inderjit Murugendrappa Gowdar, Khalid Gufran

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anjana J PratapClinical Coordinator in Dental Care Hook, Hook, UK.
Rashmi SrinathDepartment of Periodontics, College of Dental Sciences, Davangere, Karnataka, 577004, India.
N C PraveenDepartment of Periodontics, College of Dental Sciences, Davangere, Karnataka, 577004, India.
Prerana SustarwarDepartment of Periodontics, College of Dental Sciences, Davangere, Karnataka, 577004, India.
Manasa SadarjoshiDepartment of Periodontics, College of Dental Sciences, Davangere, Karnataka, 577004, India.
Sultan Abdulrahman AlmalkiDepartment of Preventive Dental Sciences, College of Dentistry, Prince Sattam bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
Inderjit Murugendrappa GowdarDepartment of Preventive Dental Sciences, College of Dentistry, Prince Sattam bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
Khalid GufranDepartment of Preventive Dental Sciences, College of Dentistry, Prince Sattam bin Abdulaziz University, Alkharj, 11942, Saudi Arabia. k.syed@psau.edu.sa.

Funding

Prince Sattam bin Abdulaziz University PSAU/2024/01/99528
6 · The paper itself

Abstract

backgroundPeriodontitis is a polymicrobial, multifactorial infection that affects the supporting structures of teeth. Melatonin, a biomolecule with anti-inflammatory, antibacterial, and antioxidant properties, has demonstrated promising results in various medical fields, including dentistry.

objectiveThis study aimed to evaluate the effectiveness of 1% (w/v) melatonin gel as an adjunct to Non-Surgical Periodontal Therapy (NSPT) in improving clinical periodontal parameters, reducing antimicrobial activity against Aggregatibacter actinomycetemcomitans and Prevotella intermedia, and increasing superoxide dismutase (SOD) levels in gingival crevicular fluid (GCF) among patients with stage II periodontitis.

methodsA split-mouth randomized controlled trial was conducted on 24 periodontitis patients. Two sites per patient were randomly assigned: the test site underwent scaling and root planing (SRP) followed by intra pocket application of 1% melatonin gel, while the control site received SRP alone. Clinical parameters, including the Plaque Index (PI), Gingival Index (GI), Gingival Bleeding Index (GBI), Periodontal Pocket Depth (PPD), and Clinical Attachment Loss (CAL), were assessed at baseline, 1 month, and 3 months. Subgingival plaque samples and GCF were collected to evaluate microbial and biochemical changes.

resultsBoth groups showed statistically significant improvements in clinical parameters from baseline to the 3rd month post-therapy. A quantitative reduction in Aggregatibacter actinomycetemcomitans and Prevotella intermedia was observed at both sites. Additionally, the test site exhibited a greater increase in SOD levels compared to the control site.

conclusionThe adjunctive application of melatonin gel with SRP demonstrated enhanced antioxidant potential and improved clinical outcomes in patients with stage II periodontitis. TRIAL REGISTRATION TRIAL REGISTRY: ISRCTN. Trial registration number ISRCTN40460432. Date of Registration: 22/10/2024. "Retrospectively registered".

Indexed as

AntioxidantsDrug Delivery SystemsMelatoninPeriodontitisAdultAggregatibacter actinomycetemcomitansDental ScalingFemaleGelsGingival Crevicular FluidHumansMaleMiddle AgedPeriodontal IndexPrevotella intermediaRoot PlaningAntioxidantsGelsMelatoninSuperoxide DismutaseClinical attachment lossGingival indexMelatoninPeriodontitisPeriodontopathogensSuperoxide dismutase

Identifiers

PMID39948592
PMCPMC11827357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.